Evidence for the involvement of SDF-1 and CXCR4 in the disruption of endothelial cell-branching morphogenesis and angiogenesis by TNF-α and IFN-γ

Journal of Leukocyte Biology

Volumn 76, Issue 1, 2004, Pages 217-226

  Salvucci, Ombretta ^a,b   Basik, Mark ^c   Yao, Lei ^a   Bianchi, Rossella ^b   Tosato, Giovanna ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF BRESCIA   (Italy)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

Author keywords

Chemokine; Cytokine; Endothelium; Inflammation

Indexed keywords

ANGIOGENESIS INHIBITOR; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; CD31 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 4; ENDOTHELIAL CELL GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MONOKINE; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRYPTOPHAN TRANSFER RNA LIGASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOTHELIUM INJURY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IN VIVO STUDY; INFLAMMATION; MORPHOGENESIS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TISSUE INJURY;

BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINES, CXC; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CXCR4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 3042737393     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1203609     Document Type: Article

References (48)

1. Aderem, A., Underhill, D. M. (1999) Mechanisms of phagocytosis in macrophages. Annu. Rev. Immunol. 17, 593-623.
2. Galli, S. J., Gordon, J. R., Wershil, B. K. (1991) Cytokine production by mast cells and basophils. Curr. Opin. Immunol. 3, 865-872.
3. Burg, N. D., Pillinger, M. H. (2001) The neutrophil: function and regulation in innate and humoral immunity. Clin. Immunol. 99, 7-17.
4. Nathan, C. (2002) Points of control in inflammation. Nature 420, 846-852.
5. Dinarello, C. A. (2000) Proinflammatory cytokines. Chest 118, 503-508.
6. Carmeliet, P. (2003) Angiogenesis in health and disease. Nat. Med. 9, 653-660.
7. Jain, R. K. (2003) Molecular regulation of vessel maturation. Nat. Med. 9, 685-693.
8. Galli, S. J., Maurer, M., Lantz, C. S. (1999) Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 11, 53-59.
9. Carmeliet, P., Jain, R. K. (2000) Angiogenesis in cancer and other diseases. Nature 407, 249-257.
10. Gordon, A. H., Koj, A., eds. (1985) The acute phase response to injury and infection. Cambridge, UK, Elsevier 10, 1-339.
11. Aggarwal, B. B., Natarajan, K. (1996) Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7, 93-124.
12. Billiau, A. (1996) Interferon-γ: biology and role in pathogenesis. Adv. Immunol. 62, 61-130.
13. Dustin, M. L., Carpen, O., Springer, T. A. (1992) Regulation of locomotion and cell-cell contact area by the LFA-1 and ICAM-1 adhesion receptors. J. Immunol. 148, 2654-2663.
14. Ruegg, C., Yilmaz, A., Bieler, G., Bamat, J., Chaubert, P., Lejeune, F. J. (1998) Evidence for the involvement of endothelial cell integrin αVβ3 in the disruption of the tumor vasculature induced by TNF and IFN-γ. Nat. Med. 4, 408-414.
15. Marfaing-Koka, A., Devergne, O., Gorgone, G., Portier, A., Schall, T. J., Galanaud, P., Emilie, D. (1995) Regulation of the production of the RANTES chemokine by endothelial cells. Synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J. Immunol. 154, 1870-1878.
16. Frater-Schroder, M., Risau, W., Hallmann, R., Gautschi, P., Bohlen, P. (1987) Tumor necrosis factor type α, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84, 5277-5281.
17. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., Strieter, R. M. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801.
18. Sgadari, C., Angiolillo, A. L., Tosato, G. (1996) Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 87, 3877-3882.
19. Sgadari, C., Angiolillo, A. L., Cherney, B. W., Pike, S. E., Farber, J. M., Koniaris, L. G., Vanguri, P., Burd, P. R., Sheikh, N., Gupta, G., Teruya-Feldstein, J., Tosato, G. (1996) Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc. Natl. Acad. Sci. USA 93, 13791-13796.
20. Kim, S., Dougherty, E. R., Bittner, M. L., Chen, Y., Sivakumar, K., Meltzer, P., Trent, J. M. (2000) General nonlinear framework for the analysis of gene interaction via multivariate expression arrays. J. Biomed. Opt. 5, 411-424.
21. Setsuda, J., Teruya-Feldstein, J., Harris, N. L., Ferry, J. A., Sorbara, L., Gupta, G., Jaffe, E. S., Tosato, G. (1999) Interleukin-18, interferon-γ IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. Am. J. Pathol. 155, 257-265.
22. Salvucci, O., Yao, L., Villalba, S., Sajewicz, A., Pittaluga, S., Tosato, G. (2002) Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 99, 2703-2711.
23. Lakhanpal, S., Gonchoroff, N. J., Katzmann, J. A., Handwerger, B. S. (1987) A flow cytofluorometric double staining technique for simultaneous determination of human mononuclear cell surface phenotype and cell cycle phase. J. Immunol. Methods 96, 35-40.
24. Angiolillo, A. L., Sgadari, C., Taub, D. D., Liao, F., Farber, J. M., Maheshwari, S., Kleinman, H. K., Reaman, G. H., Tosato, G. (1995) Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182, 155-162.
25. Yao, L., Sgadari, C., Furuke, K., Bloom, E. T., Teruya-Feldstein, J., Tosato, G. (1999) Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12. Blood 93, 1612-1621.
26. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., Alitalo, K. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15, 1751.
27. Petitclerc, E., Boutaud, A., Prestayko, A., Xu, J., Sado, Y., Ninomiya, Y., Sarras Jr., M. P., Hudson, B. G., Brooks, P. C. (2000) New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J. Biol. Chem. 275, 8051-8061.
28. Kalluri, R. (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat. Rev. Cancer 3, 422-433.
29. Yla-Herttuala, S., Alitalo, K. (2003) Gene transfer as a tool to induce therapeutic vascular growth. Nat. Med. 9, 694-701.
30. Hagiwara, K., Stenman, G., Honda, H., Sahlin, P., Andersson, A., Miyazono, K., Heldin, C. H., Ishikawa, F., Takaku, F. (1991) Organization and chromosomal localization of the human platelet-derived endothelial cell growth factor gene. Mol. Cell. Biol. 11, 2125-2132.
31. Koga, K., Todaka, T., Morioka, M., Hamada, J., Kai, Y., Yano, S., Okamura, A., Takakura, N., Suda, T., Ushio, Y. (2001) Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis. Cancer Res. 61, 6248-6254.
32. Ergun, S., Kilik, N., Ziegeler, G., Hansen, A., Nollau, P., Gotze, J., Wurmbach, J. H., Horst, A., Weil, J., Fernando, M., Wagener, C. (2000) CEA-related cell adhesion molecule 1: a potent angiogenic factor and a major effector of vascular endothelial growth factor. Mol. Cell 5, 311-320.
33. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N., Yancopoulos, G. D. (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277, 55-60.
34. Tolstrup, A. B., Bejder, A., Fleckner, J., Justesen, J. (1995) Transcriptional regulation of the interferon-γ-inducible tryptophanyl-tRNA synthetase includes alternative splicing. J. Biol. Chem. 270, 397-403.
35. Wakasugi, K., Slike, B. M., Hood, J., Otani, A., Ewalt, K. L., Friedlander, M., Cheresh, D. A., Schimmel, P. (2002) A human aminoacyl-tRNA synthetase as a regulator of angiogenesis. Proc. Natl. Acad. Sci. USA 99, 173-177.
36. Otani, A., Slike, B. M., Dorrell, M. I., Hood, J., Kinder, K., Ewalt, K. L., Cheresh, D., Schimmel, P., Friedlander, M. (2002) A fragment of human TrpRS as a potent antagonist of ocular angiogenesis. Proc. Natl. Acad. Sci. USA 99, 178-183.
37. Baker, A. H., Edwards, D. R., Murphy, G. (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727.
38. Coussens, L. M., Fingleton, B., Matrisian, L. M. (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295, 2387-2392.
39. Ferrara, N., Gerber, H. P., LeCouter, J. (2003) The biology of VEGF and its receptors. Nat. Med. 9, 669-676.
40. Newman, P. J. (1997) The biology of PECAM-1. J. Clin. Invest. 100, S25-S29.
41. Fedyk, E. R., Jones, D., Critchley, H. O., Phipps, R. P., Blieden, T. M., Springer, T. A. (2001) Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J. Immunol. 166, 5749-5754.
42. Gupta, S. K., Lysko, P. G., Pillarisetti, K., Ohlstein, E., Stadel, J. M. (1998) Chemokine receptors in human endothelial cells. Functional expression of CXCR4 and its transcriptional regulation by inflammatory cytokines. J. Biol. Chem. 273, 4282-4287.
43. Tashiro, K., Tada, H., Heilker, R., Shirozu, M., Nakano, T., Honjo, T. (1993) Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261, 600-603.
44. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A., Springer, T. A. (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J. Exp. Med. 184, 1101-1109.
45. Sierra, M. D., Yang, F., Narazaki, M., Salvucci, O., Davis, D., Yarchoan, R., Zhang, H. H., Fales, H., Tosato, G. (2004) Differential processing of stromal-derived factor-1 {α} and {β} explains functional diversity. Blood 103, 2452-2459.
46. Amara, A., Lorthioir, O., Valenzuela, A., Magerus, A., Thelen, M., Montes, M., Virelizier, J. L., Delepierre, M., Baleux, F., Lortat-Jacob, H., Arenzana-Seisdedos, F. (1999) Stromal cell-derived factor-1α associates with heparan sulfates through the first β-strand of the chemokine. J. Biol. Chem. 274, 23916-23925.
47. Yao, L., Salvacci, O., Cardones, A. R., Hwang, S. T., Aoki, Y., De La Luz Sierra, M., Sajewicz, A., Pittaluga, S., Yarchoan, R., Tosato, G. (2003) Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis. Blood 102, 3900-3905.
48. Villalba, S., Salvucci, O., Aoki, Y., Sierra Mde, L., Gupta, G., Davis, D., Wyvill, K., Little, R., Yarchoan, R., Tosato, G. (2003) Serum inactivation contributes to the failure of stromal-derived factor-1 to block HIV-I infection in vivo. J. Leukoc. Biol. 74, 880-888.